2025 Scientific Sessions

Late-Breaking Clinical Research

Balloon-Assisted Modification of the Anterior Mitral Leaflet to Prevent Outflow Track Obstruction During Transseptal Transcatheter Mitral Valve Replacement: BATMAN Collaboration
Gennaro Giustino, M.D.1, Ahmad Jabri, M.D., FSCAI2, Santiago Garcia, MD, FSCAI3, Sant Kumar4, Thom Dahle, M.D., FSCAI5, Brian O'Neill, M.D.6, Philippe Genereux MD, M.D.7, Amr E. Abbas, M.D., FSCAI8, Puvi N. Seshiah, M.D., FSCAI3, Hursh Naik, MD9, Brian M. Stegman, M.D.10, Adnan Halboni11, Raviteja Reddy Guddeti, M.D., FSCAI3, Pedro engel-Gonzalez, MD6, Tiberio Frisoli, MD6, Robert Kipperman, M.D.12, William W. O'Neill, MD, MSCAI6 and Pedro A Villablanca, M.D., FSCAI13, (1)Gagnon Cardiovascular Institute, Atlantic Health System, Morristown, New Jersey, Morristown, NJ, (2)Beaumont Health, Royal Oak, MI, (3)The Christ Hospital Health Network, Cincinnati, OH, (4)Department of Cardiology, Creighton University School of Medicine, Phoenix, AZ, (5)CentraCare Heart and Vascular Center, Clear Lake, MN, (6)Henry Ford Health System, Detroit, MI, (7)Gagnon Cardiovascular Institute at Morristown Medical Center, Morristown, NJ, (8)Beaumont Hospital - Royal Oak, Birmingham, MI, (9)Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, AZ, (10)CentraCare Heart and Vascular Center, Cleveland, OH, (11)Wayne State University, West Bloomfield, MI, (12)Atlantic Health Morristown Medical Center, Morristown, NJ, (13)Henry Ford Hospital, Detroit, MI
Safety and Feasibility of the Supira System in High-Risk Percutaneous Coronary Interventions: 30-Day Results from the US SUPPORT I Early Feasibility Study (EFS)
David E. Kandzari, M.D., MSCAI1, Andrea Mignatti, M.D.2, Annapoorna S. Kini, M.D.3, Alexandre Abizaid, M.D.4, Ricardo Campos, MD, PhD5, Gagan Singh, M.D., FSCAI6, Azeem Latib, M.D.7, Garrett B. Wong, M.D., FSCAI6 and Ricardo A. Costa, M.D., Ph.D.4, (1)Piedmont Heart Institute, Atlanta, GA, (2)Montefiore Health System, Bronx, NY, (3)Mount Sinai Hospital, New York, NY, (4)Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil, (5)Dante Pazzanese Institute of Cardiology, São Paulo, São Paulo, Brazil, (6)UC Davis Medical Center, Sacramento, CA, (7)Montefiore Medical Center, Bronx, NY
The Look Inside in the Benefit of Physiology-Guided Revascularization: From Diagnostic Value to Prognostic Implication of Quantitative Flow Ratio (QFR)
Dr. Hao-Yu Wang, MD, PhD, FSCAI, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, BC, China and Kefei Dou, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Impact of Age on Procedural Timing for Asymptomatic Severe Aortic Stenosis: Results from the Early TAVR Trial
Philippe Genereux MD, M.D.1, Allan Schwartz, M.D.2, David J. Cohen, M.D., FSCAI3, Brian Lindman, MD, MSCI4, Philippe Pibarot, DVM, Ph.D5, Yizhuo Wang, PhD6 and Martin B. Leon, M.D.2, (1)Atlantic Health System, Morristown, NJ, (2)NewYork-Presbyterian Columbia University Irving Medical Center, New York, NY, (3)St. Francis Hospital, New York, NY, (4)Vanderbilt University, Nashville, TN, (5)Laval University, Quebec Heart-Lung Institute, Québec, FL, (6)Edwards Lifesciences, Irvine, CA